CG

Cristina Ghenoiu

Mubadala Capital - Biotech Venture Capital

San Francisco, California

Invests in

Stages:

Sectors:

Medical Devices

Pharmaceuticals

Health & Hospital Services

Boston / New England

Locations:

Boston, Massachusetts

Min Investment:
$100,000.00
Max Investment:
$5,000,000.00
Target Investment:
$1,500,000.00

Skills

Biotechnology

Financial Modeling

Venture Capital

Equity Research Analysis

Valuation

Start-up Ventures

Mergers & Acquisitions

Healthcare

Capital Markets

Investments

Gene Therapy

Oncology

Drug Discovery

Biopharmaceuticals

Pharmaceutical Industry

Private Equity

Start-ups

Education

Ph.D.
Weill Cornell Graduate School of Medical Sciences
(2005 - 2012)
Scholarship Recipient And Participant In The Fundamentals Of The Biosciences Certificate Program
SUNY Stony Brook, Center For Biotechnology
(2011 - 2011)
BA
Mount Holyoke College
(2000 - 2004)
Study Abroad
The American University in Cairo
(2002 - 2003)
International baccalaureate
Pearson College UWC
(1998 - 2000)
Colegiul National Bilingv George Cosbuc
(1996 - 1998)

Investments

Capacity Bio

Total Funding: $35M

Work Experience

Mubadala Capital

2023

Senior Principal
2023

RA Capital Management, L.P.

2021 - 2023

Principal
2021 - 2023

2022 - 2023

Board Director
2022 - 2023

Superluminal Medicines, Inc.

2022 - 2023

Board Director
2022 - 2023

Rivus Pharmaceuticals

2022 - 2023

Board Observer & Scientific Co-Founder
2022 - 2023

GIVAX

2021 - 2023

Board Director
2021 - 2023

Lusaris

2021 - 2022

Board Director
2021 - 2022

2020 - 2021

SVP of R&D Ops. & New Product Planning
2020 - 2021
https://epirium.com/

Rivus Pharmaceuticals

2019 - 2021

Board Observer & Scientific Co-Founder
2019 - 2021

2018 - 2019

Board Observer
2018 - 2019